Scarica l'app Stockscreener
4.53
0.78%
-0.03
Precedente Chiudi:
$4.56
Aprire:
$4.44
Volume 24 ore:
630.07K
Relative Volume:
1.03
Capitalizzazione di mercato:
$438.38M
Reddito:
-
Utile/perdita netta:
$-238.77M
Rapporto P/E:
-0.169
EPS:
-26.808
Flusso di cassa netto:
$-216.62M
1 W Prestazione:
-5.94%
1M Prestazione:
+12.55%
6M Prestazione:
-1.43%
1 anno Prestazione:
-60.38%
Intervallo 1D:
$4.41
$4.65
Intervallo di 1 settimana:
$4.385
$4.85
Portata 52W:
$2.7601
$13.00
Alumis Inc Stock (ALMS) Company Profile
Nome
Alumis Inc
Settore
Industria
Telefono
650-231-6625
Indirizzo
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Confronta ALMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALMS
Alumis Inc
|
4.525 | 474.53M | 0 | -238.77M | -216.62M | -26.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.16 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.15 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.92 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.09 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.56 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-25 | Iniziato | Wells Fargo | Overweight |
| 2025-06-10 | Ripresa | Guggenheim | Buy |
| 2025-01-30 | Iniziato | Oppenheimer | Outperform |
| 2024-10-31 | Iniziato | Robert W. Baird | Outperform |
| 2024-10-17 | Iniziato | H.C. Wainwright | Buy |
| 2024-07-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-07-23 | Iniziato | Guggenheim | Buy |
| 2024-07-23 | Iniziato | Leerink Partners | Outperform |
| 2024-07-23 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Alumis Inc Borsa (ALMS) Ultime notizie
Alumis to Participate in Upcoming November Investor Conferences - The Manila Times
Alumis (Nasdaq: ALMS) schedules investor conference webcasts, replays for 90 days - Stock Titan
Analyzing drawdowns of Alumis Inc. with statistical toolsJuly 2025 WrapUp & Daily Profit Focused Stock Screening - newser.com
Is a relief rally coming for Alumis Inc. holdersWeekly Loss Report & Verified Stock Trade Ideas - newser.com
Real time scanner hits for Alumis Inc. explainedJuly 2025 Highlights & Real-Time Market Sentiment Alerts - newser.com
Will Alumis Inc. continue its uptrendQuarterly Performance Summary & Target Return Focused Stock Picks - newser.com
Will Alumis Inc. stock remain a Wall Street favoriteFed Meeting & Daily Growth Stock Tips - newser.com
Will Alumis Inc. stock benefit from upcoming earnings reportsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
How to manage a losing position in Alumis Inc.Weekly Stock Report & Consistent Profit Trade Alerts - newser.com
Why Alumis Inc. stock is recommended by analystsJuly 2025 Macro Moves & Entry Point Confirmation Signals - newser.com
Will Alumis Inc. stock benefit from sector rotationJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Momentum divergence signals in Alumis Inc. chart2025 Short Interest & Daily Profit Focused Screening - newser.com
Is Alumis Inc. a candidate for recovery playQuarterly Market Summary & Weekly Chart Analysis and Guides - newser.com
Chart based exit strategy for Alumis Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Is Alumis Inc. stock positioned for long term growthJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
Pattern recognition hints at Alumis Inc. upsideJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Will Alumis Inc. outperform the marketMarket Movers & Free Real-Time Volume Trigger Notifications - newser.com
Tools to assess Alumis Inc.’s risk profileJuly 2025 Action & Free Growth Oriented Trading Recommendations - newser.com
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer in Psoriasis Treatment - MSN
Sentiment Watch: Will Alumis Inc. stock outperform value stocksJuly 2025 Opening Moves & Free Technical Confirmation Trade Alerts - Fundação Cultural do Pará
Alumis Inc Azioni (ALMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Alumis Inc Azioni (ALMS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tananbaum James B. | Director |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
| Foresite Labs, LLC | 10% Owner |
May 02 '25 |
Buy |
4.62 |
25,000 |
115,500 |
4,227,670 |
| Foresite Labs, LLC | 10% Owner |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
| Foresite Capital Management VI | 10% Owner |
May 02 '25 |
Buy |
4.62 |
25,000 |
115,500 |
4,227,670 |
| Foresite Capital Management VI | 10% Owner |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
| AKKARAJU SRINIVAS | Director |
May 05 '25 |
Buy |
4.67 |
160,370 |
749,676 |
3,586,788 |
| AKKARAJU SRINIVAS | Director |
May 02 '25 |
Buy |
4.55 |
159,920 |
727,636 |
3,426,418 |
| Colowick Alan | Director |
Apr 01 '25 |
Buy |
6.97 |
16,104 |
112,309 |
16,104 |
| Colowick Alan | Director |
Apr 02 '25 |
Buy |
7.49 |
2,300 |
17,235 |
18,404 |
| Babler Martin | President, CEO and Chairman |
Apr 01 '25 |
Buy |
6.44 |
15,650 |
100,733 |
106,454 |
1.24%
0.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):